Riociguat in the Treatment of Chronic Thromboembolic Pulmonary Hypertension: An Evidence-Based Review of Its Place in Therapy

Chronic thromboembolic pulmonary hypertension (CTEPH) is classified as group-4 pulmonary hypertension caused by organized thrombi in pulmonary arteries and vasculopathy in nonoccluded areas leading to right heart failure and death. In addition to chronic anticoagulation therapy, each patient with CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Donaldson, Sahai, Ogunti, Richard, Kibreab, Angesom, Mehari, Alem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457580/
https://www.ncbi.nlm.nih.gov/pubmed/32904692
http://dx.doi.org/10.2147/CE.S172791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457580/
https://www.ncbi.nlm.nih.gov/pubmed/32904692
http://dx.doi.org/10.2147/CE.S172791

Ejemplares similares